Greenwich LifeSciences, Inc. (GLSI) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	10-K	S-1
Revenues	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	1.6	1.0	0.8	0.8	0.4
General and administrative	1.6	1.0	0.8	0.8	0.4
Research and development	6.5	3.6	1.1	2.6	1.3
EBITA	-8.0	-4.6	-1.9	-3.4	-1.7
Amortization of intangibles	0.0	0.0	0.0	0.0	0.0
EBIT [+]	-8.0	-4.6	-1.9	-3.4	-1.7
EBIT growth	74.9%	146.7%	-45.6%	102.7%
Interest income	0.2	0.0	0.0
Interest income	0.2	0.0	0.0
Pre-tax income	-7.8	-4.6	-1.9	-3.4	-1.7
Income taxes	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-7.8	-4.6	-1.9	-3.4	-1.7

Basic EPS [+]	($0.61)	($0.35)	($0.20)	($1.52)	($8.32)
Growth	74.3%	78.5%	-87.1%	-81.8%
Diluted EPS [+]	($0.61)	($0.35)	($0.20)	($1.52)	($8.32)
Growth	74.3%	78.5%	-87.1%	-81.8%

Shares outstanding (basic) [+]	12.8	13.1	9.5	2.3	0.2
Growth	-1.8%	37.5%	320.7%	1012.3%
Shares outstanding (diluted) [+]	12.8	13.1	9.5	2.3	0.2
Growth	-1.8%	37.5%	320.7%	1012.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.